{
  "zip": "5009",
  "sector": "Healthcare",
  "fullTimeEmployees": 37,
  "longBusinessSummary": "BerGenBio ASA, a clinical-stage biopharmaceutical company, develops medicines to treat immune evasive, drug resistant, and metastatic cancers. Its lead candidate is Bemcentinib, a bioavailable small molecule AXL inhibitor, which is in Phase II clinical development in two major cancer indications. The Phase II clinical trial program focuses on lung cancer, acute myeloid leukaemia, and myelodysplastic syndrome, as well as melanoma and triple negative breast cancer. In addition, it is developing tilvestamab, a function blocking antibody that is in Phase I clinical trial; and BGB601, a Phase I clinical trial antibody drug conjugate against human AXL that is linked to a cytotoxin. BerGenBio ASA has a collaboration agreement with Merck & Co. for clinical trials. The company was founded in 2007 and is headquartered in Bergen, Norway.",
  "city": "Bergen",
  "phone": "47 55 96 11 59",
  "country": "Norway",
  "companyOfficers": [],
  "website": "http://www.bergenbio.com",
  "maxAge": 1,
  "address1": "Jonas Lies vei 91",
  "industry": "Biotechnology",
  "previousClose": 3.94,
  "regularMarketOpen": 3.94,
  "twoHundredDayAverage": 3.5698957,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 3.94,
  "navPrice": null,
  "averageDailyVolume10Day": 0,
  "totalAssets": null,
  "regularMarketPreviousClose": 3.94,
  "fiftyDayAverage": 3.6841092,
  "trailingAnnualDividendRate": null,
  "open": 3.94,
  "averageVolume10days": 0,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 1.665637,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 3.94,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 100,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 389597024,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 116,
  "priceToSalesTrailing12Months": null,
  "dayLow": 3.94,
  "ask": null,
  "ytdReturn": null,
  "askSize": null,
  "volume": 100,
  "fiftyTwoWeekHigh": 4.39,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 1.23,
  "bid": null,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": null,
  "dayHigh": 3.94,
  "exchange": "PNK",
  "shortName": "BERGENBIO ASA",
  "longName": "BerGenBio ASA",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "BRRGF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_107144331",
  "uuid": "8faa095b-5b06-35c4-973a-2053f6afd55d",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 87260000,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": null,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1577750400,
  "heldPercentInstitutions": 0.27168,
  "netIncomeToCommon": null,
  "trailingEps": null,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0.30382,
  "nextFiscalYearEnd": 1640908800,
  "mostRecentQuarter": 1601424000,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 52483389,
  "enterpriseValue": 343804320,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 3.94,
  "logo_url": "https://logo.clearbit.com/bergenbio.com"
}